GEMPHARMATECH CO., LTD. — Investor Relations & Filings
About GEMPHARMATECH CO., LTD.
GemPharmatech Co., Ltd. is a global biotechnology company specializing in the development and distribution of genetically engineered mouse models (GEMMs) for biomedical research. The company maintains one of the world's largest repositories of mouse strains, including knockout (KO), conditional knockout (cKO), and humanized models designed for oncology, immunology, and metabolic disease studies. Through its Knockout All Project, GemPharmatech aims to create KO and cKO strains for all protein-coding genes in the mouse genome. Beyond model production, the company provides comprehensive preclinical services such as efficacy testing, safety assessment, phenotyping, and customized gene editing using CRISPR/Cas9 technology. Serving pharmaceutical enterprises, biotechnology firms, and academic institutions, GemPharmatech supports drug discovery and fundamental life science research with high-throughput production capabilities and specialized germ-free mouse facilities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 药康生物关于完成工商变更登记并换发营业执照的公告 | 2022-06-15 | Chinese | |
| 药康生物2021年年度股东大会决议公告 | 2022-06-07 | Chinese | |
| 江苏世纪同仁律师事务所关于江苏集萃药康生物科技股份有限公司2021年年度股东大会的法律意见书 | 2022-06-07 | Chinese | |
| 药康生物2021年年度股东大会会议资料 | 2022-05-27 | Chinese | |
| 关于开立募集资金理财产品专用结算账户的公告 | 2022-05-20 | Chinese | |
| 关于续聘2022年度审计机构的公告 | 2022-05-18 | Chinese |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 39528532 | 药康生物关于完成工商变更登记并换发营业执照的公告 | 2022-06-15 | Chinese | ||
| 39528528 | 药康生物2021年年度股东大会决议公告 | 2022-06-07 | Chinese | ||
| 39528522 | 江苏世纪同仁律师事务所关于江苏集萃药康生物科技股份有限公司2021年年度股东大会的法律意见书 | 2022-06-07 | Chinese | ||
| 39528510 | 药康生物2021年年度股东大会会议资料 | 2022-05-27 | Chinese | ||
| 39528494 | 关于开立募集资金理财产品专用结算账户的公告 | 2022-05-20 | Chinese | ||
| 39528486 | 关于续聘2022年度审计机构的公告 | 2022-05-18 | Chinese | ||
| 39528472 | 使用自有资金支付募投项目部分款项并以募集资金等额置换的核查意见 | 2022-05-18 | Chinese | ||
| 39528463 | 关于2021年度利润分配预案的公告 | 2022-05-18 | Chinese | ||
| 39528458 | 关于确认2021年度关联交易及预计2022年度日常关联交易公告 | 2022-05-18 | Chinese | ||
| 39528451 | 关于拟变更注册资本、公司类型、修订公司章程并办理工商登记的公告 | 2022-05-18 | Chinese | ||
| 39528444 | 关于未披露2021年度内部控制评价报告的说明 | 2022-05-18 | Chinese | ||
| 39528433 | 关于江苏集萃药康生物科技股份有限公司 以自筹资金预先投入募集资金投资项目及支付发行费用的鉴证报告 | 2022-05-18 | Chinese | ||
| 39528414 | 独立董事关于第一届董事会第十二次会议相关事项的独立意见 | 2022-05-18 | Chinese | ||
| 39528405 | 关于召开2021年年度股东大会的通知 | 2022-05-18 | Chinese | ||
| 39528388 | 2021年度独立董事述职报告 | 2022-05-18 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
GEMPHARMATECH CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58096/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58096 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58096 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58096 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58096}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GEMPHARMATECH CO., LTD. (id: 58096)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.